New brain injection therapy tested for deadly recurrent cancer
NCT ID NCT07386002
Summary
This study is testing an experimental cell therapy called MT027 for adults with glioblastoma, a fast-growing brain cancer, that has come back or gotten worse after standard treatment. The therapy is injected directly into the fluid-filled spaces of the brain. The main goals are to see if the treatment is safe and if it can help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Kaohsiung
Kaohsiung City, 833401, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chang Gung Memorial Hospital, Linkou
Taoyuan District, 333423, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hualien Tzu Chi Hospital
Hualien City, 970473, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Johns Hopkins Sidney Kimmel Cancer Center
Baltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.